首页> 外文期刊>Research journal of pharmacy and technology >Development and Validation of a simple and rapid RP-HPLC method for the simultaneous estimation of Amlodipine and Atorvastatin in Tablet Dosage Form
【24h】

Development and Validation of a simple and rapid RP-HPLC method for the simultaneous estimation of Amlodipine and Atorvastatin in Tablet Dosage Form

机译:一种简单快速RP-HPLC方法的开发与验证,用于同时估计氨氯地平和阿托伐他汀在片剂剂型中的同时估算

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A simple and rapid reversed phase high performance liquid chromatographic method has been developed for the simultaneous estimation of Amlodipine and Atorvastatin in tablet dosage form. The separation was achieved on a Waters Symmetry C-18 column, (150mm x 3.9mm x 5μ particle size) using Acetonitrile: KH2PO4 buffer (pH 5.8) in the proportion of 45:55, v/v as mobile phase, at a flow rate of 1.0 mL/min. Detection was carried out at 254nm using VW detector. Amlodipine and Atorvastatin gave a retention time of 2.2±0.2 min and 3.2±0.2 min respectively. The developed method was validated for specificity, linearity, accuracy, precision and robustness as per ICH guidelines. The method was found to be specific as there was no interference seen in blank and placebo injections at the retention time of the drugs. The calibration curves were found to be linear with r2 = 0.999 for both the drugs. The method was found to be accurate as the mean percent recovery of Amlodipine and Atorvastatin was within the acceptance criteria. The method was found to be precise with %RSD less than 2. The method was found to be robust as small, deliberate changes in chromatographic conditions did not alter the results of analysis significantly. The method was applied in analysis of marketed formulation and the % assay was found to be within limits.
机译:已经开发了一种简单且快速的反相高效液相色谱法,用于同时估计氨氯地平和阿托伐他汀在片剂剂型中的同时估计。使用乙腈的水对称C-18柱(150mm×3.9mm×5μ粒径)在水中进行分离:KH 2 PO 4缓冲液(pH 5.8),其比例为45:55,V / V作为流动相,以流动1.0毫升/分钟的速率。使用VW检测器在254nm处进行检测。氨氯氨脒和阿托伐他汀的保留时间分别为2.2±0.2分钟和3.2±0.2分钟。根据ICH指南,验证了开发方法的特异性,线性,准确性,精度和鲁棒性。发现该方法是特异的,因为在药物的保留时间内没有看到空白和安慰剂注射中的干扰。发现校准曲线与药物的R2 = 0.999是线性的。发现该方法是准确的,因为氨氯地平和阿托伐他汀的平均百分比在验收标准内。发现该方法精确,%RSD小于2。发现该方法是稳健的,刻意的色谱条件的变化显着改变了分析结果。该方法用于分析销售制剂分析,并发现%测定在限制范围内。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号